IDT Expands Partnership With Ansa to Broaden Global Access to Complex DNA Synthesis

Integrated DNA Technologies (IDT), a Danaher company and a global leader in genomics, and Ansa Biotechnologies, Inc., a trusted partner for DNA synthesis...

September 03, 2026 | Thursday | News
Andelyn Biosciences to Scale Up Genprex’s AAV-Based Diabetes Gene Therapy Program

Andelyn Biosciences, a leading contract development and manufacturing organization, announced that Genprex, Inc. has selected Andelyn to support scale-up...

September 03, 2026 | Thursday | News
Telix Completes BiPASS Phase 3 Enrollment, Advances PSMA-PET Imaging for Earlier Prostate Cancer Diagnosis

Telix Pharmaceuticals Limited announced completion of patient enrollment in the Phase 3 BiPASS™ study of its commercial PSMA-PET imaging agent...

September 03, 2026 | Thursday | News
Teva and Trump Administration Commit to Lowering Costs of Select Medicines for U.S. Medicaid Patients

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced a shared commitment with the Trump Administration to lower the cost...

September 02, 2026 | Wednesday | News
Eisai and Biogen’s LEQEMBI Gains Canada Recommendation for Public Reimbursement in Early Alzheimer’s Disease

Eisai Co., Ltd. and Biogen Inc., announced that Canada’s Drug Agency (CDA-AMC) has issued a final recommendation supporting public reimbursement of...

September 02, 2026 | Wednesday | News
NexLife Expands Compounded GLP-1 Program With Four Protocols Under Flat-Rate Pricing Model

NexLife, a LegitScript-certified, physician-led telehealth platform, announced that its compounded GLP-1 program now spans four protocols under a single ...

September 02, 2026 | Wednesday | News
10x Genomics Wins $4.8 Million Patent Infringement Verdict Against Parse Biosciences

10x Genomics, Inc., the life science technology leader focused on accelerating science and advancing human health, announced that a jury in the U.S. Dist...

August 31, 2026 | Monday | News
Quoin Reports Positive Interim Phase 2/3 Results for QRX003 in Netherton Syndrome

Quoin Pharmaceuticals Ltd. (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on rare and...

August 31, 2026 | Monday | News
Roche Wins FDA Approval to Expand HER2 Diagnostic Testing for Gastroesophageal Cancer

Roche  announced that it has received FDA approval for expanded use of its PATHWAY® HER2 (4B5) and VENTANA® HER2 Dual ISH DNA Probe Coc...

August 28, 2026 | Friday | News
Immuneering Advances Atebimetinib Phase 3 Trial in First-Line Metastatic Pancreatic Cancer

Immuneering Corporation, a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, shared comments followi...

August 28, 2026 | Friday | News
Globus Medical Acquires Higgs Boson Health to Advance Digital Healthcare and Surgical Intelligence

Globus Medical, Inc., a leading musculoskeletal technology company, announced the acquisition of Higgs Boson Health, a digital healthcare experience comp...

August 28, 2026 | Friday | News
Thermo Fisher Scientific Launches Orbitrap Isora Mass Spectrometers for Molecular-Level Isotope Analysis

Thermo Fisher Scientific, the world leader in serving science, introduced the Thermo Scientific Orbitrap Isora Mass Spectrometer and Orbitrap Isora Pro M...

August 27, 2026 | Thursday | News
OmicsBank Raises $2.25 Million Seed Funding to Expand Global Clinical Data Network

OmicsBank, a clinical data infrastructure company connecting fragmented hospital data for drug development and healthcare AI, announced $2.25 million in ...

August 27, 2026 | Thursday | News
Vector Science and Therapeutics Enters Investor Relations Agreement With RedChip

Vector Science and Therapeutics Corp. ("Vector" or the "Company") is pleased to announce that the Company has entered into an investo...

August 27, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close